Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals

Journal of Lipid Research

Volumn 48, Issue 4, 2007, Pages 816-825

  Bacot, Sandrine ^a   Bernoud Hubac, Nathalie ^a   Chantegrel, Bernard ^b,c   Deshayes, Christian ^b,c   Doutheau, Alain ^b,c   Ponsin, Gabriel ^a   Lagarde, Michel ^a   Guichardant, Michel ^a  

^a UNIVERSITÉ DE LYON   (France)

^b CNRS   (France)

^c Univ Lyon   (France)

Author keywords

Human blood platelets; Lipid peroxidation; Michael adducts; Rat retinas

Indexed keywords

4 HYDROXY 2(E) HEXENAL; 4 HYDROXY DODECADIENAL; 4 HYDROXYNONENAL; ALKENE DERIVATIVE; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONIC ACID; DIAMIDE; DOCOSAHEXAENOIC ACID; ETHANOLAMINE; FREE RADICAL; HYDROXY ALKENAL DERIVATIVE; PHOSPHOLIPID; THIOMALIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CHEMICAL REACTION; CONTROLLED STUDY; CYTOTOXICITY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MICHAEL ADDITION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RETINA; STREPTOZOCIN DIABETES; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ALDEHYDES; ANIMALS; BLOOD PLATELETS; CHROMATOGRAPHY, GAS; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS, UNSATURATED; HUMANS; HYDROGEN PEROXIDE; MASS SPECTROMETRY; OXIDATIVE STRESS; PHOSPHATIDYLETHANOLAMINES; RATS; RETINA; STREPTOZOCIN;

EID: 34147108629     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600340-JLR200     Document Type: Article

References (30)

1. Bryant, R. W., and J. M. Bailey. 1980. Altered lipoxygenase metabolism and decreased glutathione peroxidase activity in platelets from selenium deficient rats. Biochem. Biophys. Res. Commun. 92: 268-276.
2. Véricel, E., C. Rey, C. Calzada, P. Haond, P. H. Chapuy, and M. Lagarde. 1992. Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets. Prostaglandins. 43: 75-85.
3. Muruganandam, A., C. Drouillard, R. Thibert, R. Cheung, T. Draisey, and B. Mutus. 1992. Glutathione metabolic enzyme activities in diabetic platelets as a function of glycemic control. Thromb. Res. 67: 385-397.
4. Véricel, E., C. Januel, M. Carreras, P. Moulin, and M. Lagarde. 2004. Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabetes. 53: 1046-1051.
5. Esterbauer, H., R. J. Schaur, and H. Zollner. 1991. Chemistry and biochemistry of 4-hydroxynonenal malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11: 81-128.
6. Van Kuijk, F. J., L. L. Holte, and E. A. Dratz. 1990. 4-Hydroxyhexenal: a lipid peroxidation product derived from oxidized docosahexaenoic acid. Biochim. Biophys. Acta. 1043: 116-118.
7. Bacot, S., N. Bernoud-Hubac, N. Baddas, B. Chantegrel, C. Deshayes, A. Doutheau, M. Lagarde, and M. Guichardant. 2003. Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses. J. Lipid Res. 44: 917-926.
8. Szweda, L. I., K. Uchida, L. Tsai, and E. R. Stadtman. 1993. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Selective modification of an active-site lysine. J. Biol. Chem. 268: 3342-3347.
9. Nadkarni, D. V., and L. M. Sayre. 1995. Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 8: 284-291.
10. Malle, E., A. Ibovnik, H. J. Leis, G. M. Kostner, P. F. Verhallen, and W. Sattler. 1995. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation. Arterioscler. Thromb. Vasc. Biol. 15: 377-384.
11. Selley, M. L., M. R. Bartlett, A. L. Czeti, and N. G. Ardlie. 1998. The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron. Atherosclerosis. 140: 105-112.
12. Winter, C. K., H. J. Segall, and W. F. Haddon. 1986. Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res. 46: 5682-5686.
13. Wacker, M., D. Schuler, P. Wanek, and E. Eder. 2000. Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo. Chem. Res. Toxicol. 13: 1165-1173.
14. Guichardant, M., P. Taibi-Tronche, L. B. Fay, and M. Lagarde. 1998. Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic. Biol. Med. 25: 1049-1056.
15. Guichardant, M., N. Bernoud-Hubac, B. Chantegrel, C. Deshayes, and M. Lagarde. 2002. Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Prostaglandins Leukot. Essent. Fatty Acids. 67: 147-149.
16. Lagarde, M., P. A. Bryon, M. Guichardant, and M. Dechavanne. 1980. A simple and efficient method for platelet isolation from their plasma. Thromb. Res. 17: 210-214.
17. Siegel, M. I., R. T. McConnell, and P. Cuatrecasas. 1979. Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway. Proc. Natl. Acad. Sci. USA. 76: 3774-3778.
18. Chaudière, J., E. C. Wilhelmsen, and A. L. Tappel. 1984. Mechanism of selenium-glutathione peroxidase and its inhibition by mercaptocarboxylic acids and other mercaptans. J. Biol. Chem. 259: 43-50.
19. Juaneda, P., and G. Rocquelin. 1985. Rapid and convenient separation of phospholipids and non phosphorus lipids from rat heart using silica cartridges. Lipids. 20: 40-41.
20. Van Kuijk, F. J., A. N. Siakotos, L. G. Fong, R. J. Stephens, and D. W. Thomas. 1995. Quantitative measurement of 4-hydroxyalkenals in oxidized low-density lipoprotein by gas chromatography-mass spectrometry. Anal. Biochem. 224: 420-424.
21. Ibrahim, S., A. Djimet-Baboun, V. Pruneta-Deloche, C. Calzada, L. Lagarde, and G. Ponsin. 2006. Transfer of very low density lipoprotein- associated phospholipids to activated human platelets. J. Lipid Res. 47: 341-348.
22. Born, G. V. 1962. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194: 927-929.
23. Del Corso, A., M. Dal Monte, P. G. Vilardo, I. Cecconi, R. Moschini, S. Banditelli, M. Cappiello, L. Tsai, and U. Mura. 1998. Site-specific inactivation of aldose reductase by 4-hydroxynonenal. Arch. Biochem. Biophys. 350: 245-248.
24. Friguet, B., E. R. Stadtman, and L. I. Szweda. 1994. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J. Biol. Chem. 269: 21639-21643.
25. Kosower, N. S., E. M. Kosower, and B. Wertheim. 1969. Diamide, a new reagent for the intracellular oxidation of glutathione to the disulfide. Biochem. Biophys. Res. Commun. 37: 593-596.
26. McGrath, L. T., B. M. McGleenon, S. Brennan, D. McColl, S. McIlroy, and A. P. Passmore. 2001. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. Q. J. Med. 94: 485-490.
27. Giusto, N. M., S. J. Pasquare, G. A. Salvador, P. I. Castagnet, M. E. Roque, and M. G. Ilincheta de Boschero. 2000. Lipid metabolism in vertebrate retinal rod outer segments. Prog. Lipid Res. 39: 315-391.
28. Merimee, T. J. 1990. Diabetic retinopathy. A synthesis of perspectives. N. Engl. J. Med. 322: 978-983.
29. Guichardant, M., M. T. Berthier, L. B. Fay, P. Taibi-Tronche, and M. Lagarde. 1999. Covalent modifications of aminophospholipids by 4-hydroxynonenal. Hydrolysis of the Michael adduct by phospholipases. Chem. Phys. Lipids. 101: 196.
30. Selley, M. L., J. A. McGuiness, L. A. Jenkin, M. R. Bartlett, and N. G. Ardlie. 1988. Effect of 4-hydroxy-2,3-trans-nonenal on platelet function. Thromb. Haemost. 59: 143-146.